These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 7594424

  • 1. Relationships of blood pressure to fibrinolysis: influence of anthropometry, metabolic profile and behavioural variables.
    Cigolini M, Targher G, Seidell JC, Tonoli M, Schiavon R, Agostino G, De Sandre G.
    J Hypertens; 1995 Jun; 13(6):659-66. PubMed ID: 7594424
    [Abstract] [Full Text] [Related]

  • 2. Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men.
    Cigolini M, Targher G, Seidell JC, Schiavon R, Manara F, Zenti MG, Mattioli C, De Sandre G.
    Atherosclerosis; 1994 Apr; 106(2):139-47. PubMed ID: 8060375
    [Abstract] [Full Text] [Related]

  • 3. Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.
    De Mitrio V, De Pergola G, Vettor R, Marino R, Sciaraffia M, Pagano C, Scaraggi FA, Di Lorenzo L, Giorgino R.
    Metabolism; 1999 Aug; 48(8):960-4. PubMed ID: 10459558
    [Abstract] [Full Text] [Related]

  • 4. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR, Kjems LL, Skouby SO, Andersen LF, Jespersen J.
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [Abstract] [Full Text] [Related]

  • 5. The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents.
    Sudi KM, Gallistl S, Tröbinger M, Payerl D, Weinhandl G, Muntean W, Aigner R, Borkenstein MH.
    J Pediatr Endocrinol Metab; 2001 Jan; 14(1):85-94. PubMed ID: 11220710
    [Abstract] [Full Text] [Related]

  • 6. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT, Yu JG, Olefsky JM, Sobel BE.
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [Abstract] [Full Text] [Related]

  • 7. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, Petronelli M, Laudadio E, Giorgino R.
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [Abstract] [Full Text] [Related]

  • 8. Impaired fibrinolysis in hypertension and obesity due to high plasminogen activator inhibitor-1 level in plasma.
    Urano T, Kojima Y, Takahashi M, Serizawa K, Sakakibara K, Takada Y, Takada A.
    Jpn J Physiol; 1993 Nov; 43(2):221-8. PubMed ID: 8355419
    [Abstract] [Full Text] [Related]

  • 9. Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the Northern Sweden MONICA Study.
    Eliasson M, Asplund K, Evrin PE, Lindahl B, Lundblad D.
    Metabolism; 1994 Dec; 43(12):1579-86. PubMed ID: 7990715
    [Abstract] [Full Text] [Related]

  • 10. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Gürlek A, Bayraktar M, Kirazli S.
    Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO, Landin K, Johannsson G, Tengborn L, Bengtsson BA.
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [Abstract] [Full Text] [Related]

  • 13. Impaired fibrinolysis and insulin resistance in patients with hypertension.
    Jeng JR, Sheu WH, Jeng CY, Huang SH, Shieh SM.
    Am J Hypertens; 1996 May; 9(5):484-90. PubMed ID: 8735180
    [Abstract] [Full Text] [Related]

  • 14. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents.
    Sudi KM, Gallistl S, Weinhandl G, Muntean W, Borkenstein MH.
    Metabolism; 2000 Jul; 49(7):890-5. PubMed ID: 10910001
    [Abstract] [Full Text] [Related]

  • 15. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
    Pannacciulli N, De Mitrio V, Marino R, Giorgino R, De Pergola G.
    Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
    Aso Y, Okumura KI, Yoshida N, Tayama K, Takemura Y, Inukai T.
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
    [Abstract] [Full Text] [Related]

  • 17. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhäusl W, Pacini G, Kautzky-Willer A.
    Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
    [Abstract] [Full Text] [Related]

  • 18. Increased levels of tissue plasminogen activator antigen in essential hypertension. A population-based study in Sweden.
    Eliasson M, Jansson JH, Nilsson P, Asplund K.
    J Hypertens; 1997 Apr; 15(4):349-56. PubMed ID: 9211169
    [Abstract] [Full Text] [Related]

  • 19. Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension.
    Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Birkeland KI, Jenssen T.
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):553-9. PubMed ID: 9102176
    [Abstract] [Full Text] [Related]

  • 20. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
    Skurk T, Hauner H.
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.